نتائج البحث

TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS

• Authors : Beenal Dhooria, Senior Resident (DM Fellow)

• Source: TOFACITINIB COMPARED TO TOFACITINIB WITH MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE COLITIS: A RANDOMIZED CONTROLLED TRIAL

تفاصيل العنوان

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

• Authors : Jiang lindi, Ph.D, M.D.

• Source: Comparison of the Efficacy and Safety of Tofacitinib and Methotrexate Based on Prednisone Therapy in Patients with Active Phase of Takayasu's Arteritis: a Randomized

تفاصيل العنوان

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

• Source: An Open-Label, Phase 4, Single-Arm, Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy With Tofacitinib in Adult

تفاصيل العنوان

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

• Source: A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)

تفاصيل العنوان

Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden (ODEN)

• Source: Observational Study of Tofacitinib in Ulcerative Colitis in Sweden (ODEN)

تفاصيل العنوان

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

• Source: OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITISBenchimol EI,

تفاصيل العنوان

Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications

• Source: A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory ComplicationsPanes J, Sandborn

تفاصيل العنوان

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis (TOFAST)

• Source: Evaluation of the Clinical Benefit of ToFAcitinib Treatment in Patients With Moderate to Severe Ulcerative Colitis Under Real-life Conditions of Use: TOFAst Study

تفاصيل العنوان

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome

• Source: Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome; a Phase Ib-IIa Placebo-controlled Clinical Trial and Associated Mechanistic Studies

تفاصيل العنوان

Tofacitinib for Immune Skin Conditions in Down Syndrome

• Authors : National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

• Source: Safety and Efficacy of Tofacitinib for Immune Skin Conditions in Down SyndromeRachubinski AL, Estrada BE, Norris D, Dunnick CA, Boldrick JC, Espinosa JM. Janus

تفاصيل العنوان